Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
<h4>Purpose</h4>To evaluate the feasibility of using skeletal muscle mass (SMM) at C3 (C3 SMM) as a diagnostic marker for sarcopenia in head and neck cancer (HNC) patients.<h4>Methods</h4>We evaluated 165 HNC patients and 42 healthy adults who underwent 18F-fluorodeoxyglucose...
Saved in:
Main Authors: | , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/bd88108ca34f4c4780a7a19842811b3d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|